BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29775121)

  • 1. A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.
    Sun L; Fahey P; Zhu X; Ng W; Chen ZP; Qiu Y; Lai H; Lin J; Lin L
    Integr Cancer Ther; 2018 Sep; 17(3):902-911. PubMed ID: 29775121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
    Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
    Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
    Lu HL; Su YC; Lin MC; Sun MF; Huang ST
    Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Chinese Herbal Medicine on the Survival of Colorectal Cancer Patients With Liver-Limited Metastases: A Retrospective Cohort Study, 2008 to 2017.
    Shao C; Zuo Q; Lin J; Yu RJ; Fu Y; Xiao M; Sun LL; Lin L
    Integr Cancer Ther; 2019; 18():1534735419883687. PubMed ID: 31658839
    [No Abstract]   [Full Text] [Related]  

  • 7. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.
    Tsai TY; Livneh H; Hung TH; Lin IH; Lu MC; Yeh CC
    BMJ Open; 2017 Jan; 7(1):e014571. PubMed ID: 28122837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients.
    Feng YM; Feng CW; Lu CL; Lee MY; Chen CY; Chen SC
    Jpn J Clin Oncol; 2015 Apr; 45(4):336-42. PubMed ID: 25646358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients.
    Chen LY; Zhai XF; Chen Z; Zhu JF; Qian PA; Zhao HT; Ling CQ
    Oncotarget; 2017 May; 8(18):30471-30476. PubMed ID: 27791987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of hepatectomy combined with Jianpi Huayu Therapy for hepatocellular carcinoma.
    Zhong C; Li HD; Liu DY; Xu FB; Wu J; Lin XM; Guo RP
    Asian Pac J Cancer Prev; 2014; 15(14):5951-7. PubMed ID: 25081728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow-up.
    Sun Z; Liang ST; Zhai XF; Lang QB; Zhou QH; Yue XQ; He J; Xu J; Zhu Y; Ling CQ
    J Tradit Chin Med; 2012 Jun; 32(2):156-63. PubMed ID: 22876437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Shu X; McCulloch M; Xiao H; Broffman M; Gao J
    Integr Cancer Ther; 2005 Sep; 4(3):219-29. PubMed ID: 16113029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study.
    Kuo YT; Liao HH; Chiang JH; Wu MY; Chen BC; Chang CM; Yeh MH; Chang TT; Sun MF; Yeh CC; Yen HR
    Integr Cancer Ther; 2018 Jun; 17(2):411-422. PubMed ID: 28774207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
    Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
    Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
    J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
    Liu J; Liu X; Ma J; Li K; Xu C
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31713581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.
    Dhooge M; Coriat R; Mir O; Perkins G; Brezault C; Boudou-Rouquette P; Goldwasser F; Chaussade S
    Oncology; 2013; 84(1):32-8. PubMed ID: 23076239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
    Abou-Alfa GK; Johnson P; Knox JJ; Capanu M; Davidenko I; Lacava J; Leung T; Gansukh B; Saltz LB
    JAMA; 2010 Nov; 304(19):2154-60. PubMed ID: 21081728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Chinese herbal medicine as an adjuvant therapy to reduce incidence of chronic hepatitis in colon cancer patients: A Taiwanese population-based cohort study.
    Lin TH; Yen HR; Chiang JH; Sun MF; Chang HH; Huang ST
    J Ethnopharmacol; 2017 Apr; 202():225-233. PubMed ID: 28330722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese medicine herbal treatment based on syndrome differentiation improves the overall survival of patients with unresectable hepatocellular carcinoma.
    Man YN; Liu XH; Wu XZ
    Chin J Integr Med; 2015 Jan; 21(1):49-57. PubMed ID: 25533651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.